Looking at 2021:
what lies ahead for newborn screening?
Molecular testing in newborn screening: how far we’ve come
In her presentation, Professor Mei Baker of the University of Wisconsin Department of Pediatrics discusses the state of molecular testing in newborn screening. Wisconsin’s screening program covers 47 disorders, including hemoglobinopathies, fatty acid disorders, amino acid disorders and the latest addition, spinal muscular atrophy (SMA). Learn some of the latest results and insights in molecular testing.
Watch Webinar Now